| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/ERC.09.119 |
| P698 | PubMed publication ID | 19900015 |
| P50 | author | Carlos Escobar | Q96032295 |
| P2093 | author name string | Vivencio Barrios | |
| P2860 | cites work | Structural mechanism for statin inhibition of HMG-CoA reductase | Q27631717 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial | Q28273112 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
| Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations | Q33854955 | ||
| Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor | Q33938741 | ||
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis | Q34016806 | ||
| A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin | Q34147689 | ||
| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). | Q34214164 | ||
| Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial | Q34501729 | ||
| The safety of statins in clinical practice | Q34636135 | ||
| Rosuvastatin in older patients with systolic heart failure | Q34710349 | ||
| Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial | Q34817061 | ||
| Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) | Q35605494 | ||
| Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers | Q35804141 | ||
| Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients | Q36011187 | ||
| Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. | Q36480698 | ||
| Statin use in heart failure: a cause for concern? | Q36529265 | ||
| The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials | Q36603759 | ||
| Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound. | Q36695628 | ||
| The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk | Q36752067 | ||
| Lipid screening and cardiovascular health in childhood | Q37205462 | ||
| A randomized trial of rosuvastatin in the prevention of venous thromboembolism | Q37262627 | ||
| Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial | Q38398357 | ||
| Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial | Q38473723 | ||
| Lipid levels after acute coronary syndromes | Q38501428 | ||
| Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States | Q38994564 | ||
| Rosuvastatin-induced arrest in progression of renal disease | Q42624458 | ||
| Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study | Q43646061 | ||
| No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor | Q44167271 | ||
| Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure | Q44192419 | ||
| Forty-year mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries Study | Q44197742 | ||
| Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
| Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin | Q44368437 | ||
| Statin treatment in children with familial hypercholesterolemia: the younger, the better | Q44416450 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging | Q44667938 | ||
| Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial | Q44783935 | ||
| Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study | Q44839264 | ||
| Safety of rosuvastatin | Q45089773 | ||
| Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. | Q45915774 | ||
| Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. | Q46001657 | ||
| Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries | Q46088365 | ||
| Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design | Q46353085 | ||
| Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using R | Q46429835 | ||
| Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study | Q46489522 | ||
| Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis | Q46610834 | ||
| Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study | Q46628338 | ||
| The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin. | Q46637349 | ||
| A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study | Q46688401 | ||
| Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial | Q46738022 | ||
| Dose-dependent effect of rosuvastatin treatment on urinary protein excretion. | Q46825560 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 1317-1327 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Expert Review of Cardiovascular Therapy | Q15733727 |
| P1476 | title | Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. | |
| P478 | volume | 7 |
| Q42975066 | Appropriate candidates for statin use in heart failure |
| Q38881481 | Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes |
| Q38009305 | Novel cardiac-specific biomarkers and the cardiovascular continuum |
| Q26783220 | Pleiotropic effects of statins |
| Q34894749 | Pleiotropic effects of the HMG-CoA reductase inhibitors |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q41369308 | Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. |
| Q37682793 | The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease |
Search more.